EBIT at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Plus components not separately reported this period.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's EBIT?
- Xenon Pharmaceuticals (XENE) reported EBIT of -$112.33M in Q1 2026.
- How has Xenon Pharmaceuticals's EBIT changed year-over-year?
- Xenon Pharmaceuticals's EBIT decreased by 54.4% year-over-year, from -$72.74M to -$112.33M.
- What is the long-term trend for Xenon Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's EBIT has grown at a 47.4% compound annual growth rate (CAGR), from -$78.99M to -$373.07M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.